A Silenced vanA Gene Cluster on a Transferable Plasmid Caused an Outbreak of Vancomycin-Variable Enterococci.

Antimicrob Agents Chemother

Research Group for Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, University of Tromsø-The Arctic University of Norway, Tromsø, Norway Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control,

Published: July 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

We report an outbreak of vancomycin-variable vanA(+) enterococci (VVE) able to escape phenotypic detection by current guidelines and demonstrate the molecular mechanisms for in vivo switching into vancomycin resistance and horizontal spread of the vanA cluster. Forty-eight vanA(+) Enterococcus faecium isolates and one Enterococcus faecalis isolate were analyzed for clonality with pulsed-field gel electrophoresis (PFGE), and their vanA gene cluster compositions were assessed by PCR and whole-genome sequencing of six isolates. The susceptible VVE strains were cultivated in brain heart infusion broth containing vancomycin at 8 μg/ml for in vitro development of resistant VVE. The transcription profiles of susceptible VVE and their resistant revertants were assessed using quantitative reverse transcription-PCR. Plasmid content was analyzed with S1 nuclease PFGE and hybridizations. Conjugative transfer of vanA was assessed by filter mating. The only genetic difference between the vanA clusters of susceptible and resistant VVE was an ISL3-family element upstream of vanHAX, which silenced vanHAX gene transcription in susceptible VVE. Furthermore, the VVE had an insertion of IS1542 between orf2 and vanR that attenuated the expression of vanHAX Growth of susceptible VVE occurred after 24 to 72 h of exposure to vancomycin due to excision of the ISL3-family element. The vanA gene cluster was located on a transferable broad-host-range plasmid also detected in outbreak isolates with different pulsotypes, including one E. faecalis isolate. Horizontally transferable silenced vanA able to escape detection and revert into resistance during vancomycin therapy represents a new challenge in the clinic. Genotypic testing of invasive vancomycin-susceptible enterococci by vanA-PCR is advised.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914660PMC
http://dx.doi.org/10.1128/AAC.00286-16DOI Listing

Publication Analysis

Top Keywords

susceptible vve
16
vana gene
12
gene cluster
12
silenced vana
8
outbreak vancomycin-variable
8
vve
8
faecalis isolate
8
resistant vve
8
isl3-family element
8
vana
6

Similar Publications

Prevalence of Vancomycin-Variable Enterococci from the Bloodstream in the Korea Global Antibiotic Resistance Surveillance System, 2017-2022.

Antibiotics (Basel)

December 2024

Division of Antimicrobial Resistance Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju-si 28159, Republic of Korea.

Vancomycin-variable enterococci (VVE), though genetically containing genes, are phenotypically sensitive to vancomycin. If VVE is undetected or does not grow on the vancomycin-resistant enterococci (VRE) selection medium, or both, it can acquire resistance upon exposure to vancomycin. This characteristic is clinically important for the treatment and prevention of VRE.

View Article and Find Full Text PDF

Characteristics and Prevalence of Vancomycin-variable Enterococcus faecium bacteremia in southern Taiwan.

J Microbiol Immunol Infect

December 2024

Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Laboratory Medicine, Kaohsiung Medical University H

Article Synopsis
  • Vancomycin-variable enterococci (VVE) are a type of Enterococcus faecium that carry the vanA gene but appear susceptible to vancomycin, making them difficult to detect and potentially dangerous for treatment and infection control.
  • This study, conducted in southern Taiwan from 2017 to 2021, analyzed patients with vancomycin-susceptible E. faecium bacteremia to find the prevalence of VVE and identify clinical risk factors.
  • Out of 142 patients, 21 had VVE, with higher resistance rates to certain antibiotics; malignancy and central venous catheter use were identified as significant risk factors, while VVE presence did not correlate with increased mortality, though one case of
View Article and Find Full Text PDF

BackgroundVancomycin-resistant enterococci (VRE) are increasing in Denmark and Europe. Linezolid and vancomycin-resistant enterococci (LVRE) are of concern, as treatment options are limited. Vancomycin-variable enterococci (VVE) harbour the gene complex but are phenotypically vancomycin-susceptible.

View Article and Find Full Text PDF

Vancomycin variable (VVE) bacteria are phenotypically susceptible to vancomycin, but they harbor the gene. We aimed to ascertain the prevalence of VVE among clinically isolated vancomycin-susceptible (VSE) isolates, as well as elucidate the molecular characteristics of the gene cluster within these isolates. Notably, we investigated the prevalence and structure of the gene cluster of VVE.

View Article and Find Full Text PDF